• 800.982.7922
  • info@MastersRx.com
  • es_PR ES
    es_PR ES en_US EN
MastersRx.com
  • Home
  • About
    • About
    • NABP®
  • Products
  • Resources
    • Resources
    • Track Pedigree
    • Payments
    • Online Payments
    • Careers
    • DSCSA Information
    • Store Help
  • Tradeshows
  • Blog
  • Contact
  • en_USEnglish
  • Register
  • Sign-In
Menu

The Pharmacy Post

News you can use

Content Categories COVID-19 UpdatesIndustry NewsMarketing MattersMasters News
advair generic
Mar 15, 2023

New Generic Launch—Get Advair Generic Now!

Industry NewsMasters News

The combination steroid and bronchodilator inhaler Advair is now under generic manufacturing via Prasco through a partnership with the brand manufacturer GSK. The inhaler has sold over $938 million in the United States alone to treat asthma, COPD, chronic bronchitis, and emphysema. GSK retains pediatric exclusivity for Advair® until August 2026.

Prasco CEO Chris Arington said “The Prasco authorized generic, fluticasone propionate and salmeterol Inhalation Powder will provide patients with the same quality and experience as the brand product.”

Masters is proud to offer our customers Advair generic allowing them to both save money on their bottom line and pass along savings to their customers. With a product as frequently used as Advair generic, make sure your pharmacy has all the product it needs to meet demand. Give your account manager a call today to secure your stock!

More info about Advair Generic from GSK—

ADVAIR treats two of the leading causes of asthma symptoms—airway constriction and airway inflammation—to help prevent symptoms in the first place. Results may vary. People do not use ADVAIR to relieve sudden breathing problems, and it won’t replace a rescue inhaler.

If you are on a long-term asthma control medicine, such as an inhaled corticosteroid, and your symptoms keep coming back, talk to your doctor and find out if ADVAIR may be right for you.

Your doctor should determine that a long-term asthma control medicine, such as an inhaled corticosteroid, is not adequately controlling your asthma before using ADVAIR.

Doctors prescribe the ADVAIR DISKUS to treat asthma in patients four years and older, and they prescribe ADVAIR HFA to treat asthma in patients 12 years and older. Patients who are well-controlled with an asthma control medicine, such as an inhaled corticosteroid (ICS) medicine, should not use ADVAIR. The ADVAIR is for adults and children with asthma who need both an ICS and long-acting beta2-adrenergic agonist (LABA) medicine.

(Product images are for illustrative purposes only and may differ from the actual products.)

Return to Blog

Recent Posts

  • Reward Your Loyal Customers
  • Generic Myrbetriq Approved & Launched in US
  • Ear Cleaning Products & Your Pharmacy
  • Is Your Pharmacy Ready for the Holidays?
  • Quiet Quitting—A Costly Employee Epidemic

Archives

  • 2024
    • mayo
    • abril
    • marzo
  • 2023
    • noviembre
    • agosto
    • julio
    • junio
    • abril
    • marzo
    • enero
  • 2022
    • noviembre
    • octubre
    • septiembre
    • agosto
    • junio
    • mayo
    • abril
    • marzo
    • febrero
    • enero
  • 2021
    • diciembre
    • octubre
    • septiembre
    • julio
    • junio
    • mayo
    • marzo
    • enero
  • 2020
    • diciembre
    • noviembre
    • octubre
    • septiembre
    • agosto
    • julio
    • junio
    • mayo
    • abril
    • febrero

Categories

  • COVID-19 Updates
  • Industry News
  • Marketing Matters
  • Masters News

Pages

  • Home
  • About
  • Careers
  • NABP®
  • Products
  • Resources
  • Contact us
  • Store Help
  • Register
  • Shipping Times
  • Track Pedigrees
  • Online Payments
  • ACH Pay & Save
  • Tradeshows
  • Blog
  • DSCSA Information

Contact Us

3600 Pharma Way, Mason, Ohio 45036

info@MastersRx.com

800.982.7922

800.201.6610

white logo
pills in a blister back

Copyright © 2025. Masters Pharmaceutical is a sales and marketing division of Masters Drug Company, Inc. All Rights Reserved.
This material may not be published, broadcast, rewritten or redistributed in any form without written permission from Masters Drug Company, Inc.
The images shown do not necessarily reflect the actual image of the product.

View Privacy Notice  |  View Terms of Use